中文
Medical

Articles 1

Puhe Biopharma's EGFR inhibitor YK-029A publicly released R&D data in the European Journal of Medical Chemistry
Puhe Biopharma's EGFR inhibitor YK-029A publicly released R&D data in the European Journal of Medical Chemistry
EuropeanJournalofMedicalChemistry

Recently, Puhe Biopharma disclosed the development process of its Phase 3 small molecule EGFR inhibitor YK-029A in the European Journal of Medical Chemistry.

2023-06-25
About Us
Company Profile Development History Company Layout
Business Development
R&D System Product Pipelines Patient Recruitment
Strategic Cooperation
External License Out-licensing In-licensing
News Center
Company News
Join Us
Corporate Culture Hot Jobs
Contact Us
Contact Information Feedback
官方公众号

Scan to follow
the official public account

Links
拾玉
GO

Copyright 2023 Suzhou Puhe Biopharma Co., Ltd. 苏 ICP备 2023036064

Site Map Privacy Policy Legal Notices